Navigating Market Trends, Personal Finance Tips, and Economic Insights
Popular

U.S. stocks fell to their worst loss since Election Day as the rally that Wall Street got from last week’s victory for Donald Trump and a cut to interest rates by the Federal Reserve kept fading.

The S&P 500 sank 1.3% Friday to close a losing week. The Dow Jones Industrial Average dropped 0.7%, and the Nasdaq composite fell 2.2%.

Moderna and other makers of vaccines helped drag the market down after President-elect Donald Trump named Robert F. Kennedy Jr., an anti-vaccine activist, to be his health secretary. Treasury yields swung following stronger-than-expected reports on the economy.

On Friday:

The S&P 500 fell 78.55 points, or 1.3%, to 5,870.62.

The Dow Jones Industrial Average fell 305.87 points, or 0.7%, to 43,444.99.

The Nasdaq composite fell 427.53 points, or 2.2%, to 18,680.12.

The Russell 2000 index of smaller companies fell 33.10 points, or 1.4%, to 2,303.84.

For the week:

The S&P 500 is down 124.92 points, or 2.1%.

The Dow is down 544 points, or 1.2%.

The Nasdaq is down 606.66 points, or 3.1%.

The S&P 500 is up 1,100.79 points, or 23.1.

The Dow is up 5,755.45 points, or 15.3%.

The Nasdaq is up 3,668.77 points, or 24.4%.

The Russell 2000 is up 276.76 points, or 13.7%.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now…

See The Five Stocks Here

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

Share this article
Shareable URL
Prev Post
Next Post
Leave a Reply

Your email address will not be published. Required fields are marked *

Read next
VKTX Viking Therapeutics $64.68 +14.27 (+28.31%) (As of 07/25/2024 ET) 52-Week Range $8.28 ▼ $99.41 Price Target…
Key Points The double-digit run in Tyson stock is due to lower chicken costs. This effect is sure to spillover…
Key Points Investors are taking a breather after the Federal Reserve’s nod to interest rate cuts sent…